Not applicableAvailableNCT05974410
What this trial is testing
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Who this might be right for
GlioblastomaSquamous Cell CarcinomaHodgkin Lymphoma+14 more
AVM Biotechnology Inc